American Public Health Association (APHA)

APHA executive director to address congressional subcommittee during May 13 briefing on COVID-19

Newswise — Public health and safety must be paramount when taking action to reopen the nation during the coronavirus pandemic, Georges Benjamin, MD, executive director of the American Public Health Association, will tell Congress tomorrow. Benjamin will share expert information with the House Subcommittee on Oversight and Reform’s Select Subcommittee on the Coronavirus Crisis on May 13 as part of an invited panel.

Other panelists in the congressional briefing will virtually address plans to guide federal and state work on testing, tracing and targeted containment before reopening, according to the committee. The hearing, which will be livestreamed, begins at 3 p.m. ET.

“Congress and the American people need to hear directly from experts to get the ground truth and determine specific steps we need to take to develop a coordinated and comprehensive testing, tracing and supported isolation plan to reopen the country,” according to a statement from the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James Clyburn, D-S.C., the House majority whip.

Benjamin, who has led APHA as executive director since 2002, is a former secretary for health for the state of Maryland and is regularly sought for his expertise on health issues impacting the nation, particularly during the ongoing coronavirus crisis. During his career, Benjamin has been a leader in the response to many public health emergencies, including the 2001 anthrax letter attacks, the 2003 SARS outbreak and the growing health threats of climate change.

During tomorrow’s congressional briefing, Benjamin will discuss the front-line public health response to the pandemic, the disproportionate impact COVID-19 is having on minority communities and the need for building an adequate and sustainable public health system.

Other experts slated to testify before the House subcommittee are: Scott Gottlieb, MD, former commissioner of the Food and Drug Administration; Tom Inglesby, MD, director of the Center for Health Security at the Johns Hopkins Bloomberg School of Public Affairs; Ashish Jha, MD, MPH, director of the Harvard Global Health Institute; and Mark McClellan, MD, PhD, former administrator of the Centers for Medicare and Medicaid Services.

The briefing is the first from the select subcommittee, which was created in April to oversee the federal response to the coronavirus crisis.

                                                                                             ###

APHA champions the health of all people and all communities. We strengthen the public health profession. We speak out for public health issues and policies backed by science. We are the only organization that combines a nearly 150-year perspective, a broad-based member community and the ability to influence federal policy to improve the public’s health. Visit us at www.apha.org.




Filters close

Showing results

110 of 3321
Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 5:50 PM EDT
AERA and OECD to Co-Host Webinar on Education Research Worldwide in a Covid and Post-Covid World
American Educational Research Association (AERA)

The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.

Newswise: 243232_web.jpg
Released: 17-Sep-2020 4:20 PM EDT
Study shows first proof that a safer UV light effectively kills virus causing COVID-19
Hiroshima University

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Newswise:Video Embedded american-academy-of-dermatology-honors-detroit-physician-iltefat-h-hamzavi-with-national-patient-care-hero-award
VIDEO
Released: 17-Sep-2020 4:00 PM EDT
American Academy of Dermatology honors Detroit physician Iltefat H. Hamzavi with national “Patient Care Hero” award
American Academy of Dermatology

The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Sep-2020 11:00 AM EDT Released to reporters: 17-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Sep-2020 3:05 PM EDT
New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test
Mount Sinai Health System

The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood


Showing results

110 of 3321

close
1.11395